Xeomin (incobotulinumtoxinA) is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a short period of time (temporary).
Xeomin® is made through a unique precision manufacturing process called XTRACT Technology™, that uses two filtration steps to isolate the therapeutic component of the molecule and removes the unnecessary proteins that don’t play an active role in treatment. Xeomin® is a double filtered neurotoxin.
Merz reports that “*In clinical studies, no patients demonstrated a secondary lack of treatment response due to neutralizing antibodies.” The potential advantage lies in the lessened likelihood of antibodies being formed to the proteins, which for a very limited number of patients – can render the product ineffective. (This typically is only seen in patients who have used botulinum toxin for an extended period of time.)